Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Yet if the beat and raise parade marches on, valuation may matter less, in our view. Leaders and laggards AnaptysBio (NASDAQ: ANAB) shares tumbled 30% between Tuesday and Thursday after Eli Lilly (NYSE: LLY) presented slides during its third quarter earnings call showing that the company ended the Phase IIb RESOLUTION-1 trial (NCT05516758) assessing peresolimab in rheumatoid arthritis
in low-HDI countries, 1 in 27 will be diagnosed, and 1 in 48 will die (12, 13)
(2023) 41:145065.e8
GLP-1s are generally well-tolerated with manageable side effects
US$ 26.56
US$ 29.74
US$ 23.24
US$ 21.54
US$ 20.91
US$ 28.13
US$ 24.20
US$ 27.75
US$ 23.83
US$ 28.35
US$ 22.69
US$ 29.59
US$ 22.42
US$ 22.21
US$ 27.38
